TPP functions to capture the macroeconomic shift of China’s market interest in healthcare innovation by providing North American and European companies the access to capital, manufacturing and distribution in China. Specializing in cross-border deal flow and targeted at China’s healthcare industry, TPP has created a business platform to facilitate and support the massive demand for deals.

Legacy Healthcare expands in China

CHIPS 2018

In China, March 15-17 2018, we will be hosting 100 Western healthcare companies specializing in innovative technologies in areas that are vital to the growing Chinese healthcare industry, along with approximately 1,000 Chinese healthcare strategic partners and investors.

China is relevant, accessible and seeking innovation.

The numbers are only growing across the board for healthcare needs and innovative opportunity.

0

China’s 2020 Prescription Market (billions)

0

Lung Cancer Epidemic (thousands)

0

Life science venture capital growth in one year (x)

500

TPP’s growing network

Work with us and expect real partners, deal-flow, results and progress.

TPP Healthcare prides itself as the leading platform to facilitate partnerships between both innovator and investor.

With an experienced team of well-connected industry veterans from all over the world, and the largest network in China’s healthcare industry, TPP has become the market expert with the top-notch network to execute and support cross-border transactions involving pharmaceuticals, medical devices and diagnostics.

Contact Us

TPP has the background, credentials and understanding to execute and support transactions involving global healthcare. Our team of analysts can quickly evaluate the potential for your company or product. Contact us today to discuss immediate opportunities – or simply sign up for our quarterly reports, client break-throughs and more.